Lucas Hoffman
University of Washington
H-index: 48
North America-United States
Top articles of Lucas Hoffman
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
The end of the reign of a “master regulator’’? A defect in function of the LasR quorum sensing regulator is a common feature of Pseudomonas aeruginosa isolates | Mbio | Mylène C Trottier Thays de Oliveira Pereira Marie-Christine Groleau Lucas R Hoffman Ajai A Dandekar | 2024/2/5 |
Understanding the clinical implications of the “non-classical” microbiome in chronic lung disease: a viewpoint | Steven L Taylor Aurélie Crabbé Luke R Hoffman James D Chalmers Geraint B Rogers | 2024/2/1 | |
Optimization of Human DNA Depletion and Microbial-enrichment Techniques in DNA Extraction From Oropharyngeal Swabs: Preparing for Shotgun Metagenomic Analysis in the PROMISE … | DC Bouzek CE Pope DJ Wolter CJ Miller HS Hayden | 2024/5 | |
Upper Respiratory Microbiota and Lower Respiratory Disease in Hospitalized Children in Kenya: A Secondary Pilot Analysis of the Toto Bora Trial | LE Ellington B Singa K Tickell P Pavlinac D Rwigi | 2024/5 | |
Reverse‐engineered exclusive enteral nutrition in pediatric Crohn's disease: A pilot trial | Journal of Pediatric Gastroenterology and Nutrition | Dale Lee Kim Braly Mason Nuding Ian Braly Courtney Hopp | 2024/4/1 |
Alterations in the fecal microbiota in patients with advanced cystic fibrosis liver disease after 6 months of elexacaftor/tezacaftor/ivacaftor | Journal of Cystic Fibrosis | Jennifer T Duong Christopher E Pope Hillary S Hayden Carson Miller Stephen J Salipante | 2024/3/6 |
WS05. 06 Phase 1/2a randomized, double-blind, placebo-controlled study: safety, Pk, and Efficacy outcome measures of inhaled Gallium Citrate (AR-501) in P Aeruginosa infected … | Journal of Cystic Fibrosis | A Cohen N Lechtzin S Boas T Pena K McBennett | 2023/6/1 |
Polymicrobial infections and antibiotic treatment patterns for cystic fibrosis pulmonary exacerbations | Journal of Cystic Fibrosis | Anna V Faino Lucas R Hoffman Ronald L Gibson Matthew P Kronman David P Nichols | 2023/7/1 |
Pseudomonas aeruginosa Evasion of Neutrophil Antibacterial Functions in Early Cystic Fibrosis Lung Infection | Kelly Kwong | 2023 | |
WS13. 05 The short-and long-term effects of antibiotic treatment on the oropharyngeal and fecal microbiota in infants with cystic fibrosis | Journal of Cystic Fibrosis | L Hoffman H Hayden M Nelson S Ross A Vo | 2023/6/1 |
Characterization of cerebrospinal fluid (CSF) microbiota at the time of initial surgical intervention for children with hydrocephalus | Plos one | Shailly Pandey Kathryn B Whitlock Matthew R Test Paul Hodor Christopher E Pope | 2023/6/21 |
Pharmacologic improvement of CFTR function rapidly decreases sputum pathogen density, but lung infections generally persist | The Journal of Clinical Investigation | David P Nichols Sarah J Morgan Michelle Skalland Anh T Vo Jill M Van Dalfsen | 2023/5/15 |
A Refined, Controlled 16S rRNA Gene Sequencing Approach Reveals Limited Detection of Cerebrospinal Fluid Microbiota in Children with Bacterial Meningitis | Microbiology Spectrum | Christopher E Pope Kathryn B Whitlock Paul Hodor David D Limbrick Jr Patrick J McDonald | 2023/6/15 |
147 A multitargeted approach to identify sputum and blood inflammatory cell responses to AR-501 as a measure of treatment response in people with cystic fibrosis | Journal of Cystic Fibrosis | M Saavedra N Rysavy K Poch D Wolter L Hoffman | 2023/10/1 |
Mo1885 FECAL MICROBIOTA CHANGES IN CHILDREN WITH CYSTIC FIBROSIS WITH 1 MONTH OF CFTR MODULATOR THERAPY ELEXACAFTOR/TEZACAFTOR/IVACAFTOR: PRELIMINARY FINDINGS FROM THE PROMISE … | Gastroenterology | Jennifer T Duong Christopher E Pope Hillary S Hayden Carson Miller Daniel Raftery | 2023/5/1 |
P228 In vitro evolution of levofloxacin resistance in lineages of clinical Pseudomonas aeruginosa isolates cultured at different stages of infection from people with cystic … | Journal of Cystic Fibrosis | CM Sloan LJ Sherrard GG Einarsson LR Hoffman MM Tunney | 2023/6/1 |
46 Identifying putative volatile biomarkers for methicillin-resistant Staphylococcus aureus and small-colony variant subtypes | Journal of Cystic Fibrosis | D Gutierrez-Munoz H Bean L Hoffman B Wagner D Wolter | 2023/10/1 |
Mo1716 REVERSE-ENGINEERED EXCLUSIVE ENTERAL NUTRITION IN ACTIVE PEDIATRIC CROHN'S DISEASE: IMPACT ON DISEASE AND THE INTESTINAL MICROBIOME | Gastroenterology | Dale Lee Kimberly Braly Mason E Nuding Ian Braly Courtney Hopp | 2023/5/1 |
EPS5. 02 Faecal microbiota changes in patients with cystic fibrosis with 6 months of elexacaftor/tezacaftor/ivacaftor: preliminary findings from the PROMISE study | Journal of Cystic Fibrosis | JT Duong CE Pope HS Hayden C Miller D Raftery | 2023/6/1 |
Antibiotic regimen changes during cystic fibrosis pediatric pulmonary exacerbation treatment | Annals of the American Thoracic Society | Jonathan D Cogen Don B Sanders James E Slaven Anna V Faino Ranjani Somayaji | 2023/9 |